THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS NOT ESSENTIAL FOR MOUSE DEVELOPMENT OR FERTILITY

被引:191
|
作者
BUGGE, TH
SUH, TT
FLICK, MJ
DAUGHERTY, CC
ROMER, J
SOLBERG, H
ELLIS, V
DANO, K
DEGEN, JL
机构
[1] CHILDRENS HOSP RES FDN,DIV PATHOL,CINCINNATI,OH 45229
[2] THROMBOSIS RES INST,LONDON SW3 6LR,ENGLAND
[3] RIGSHOSP,FINSEN LAB,DK-2100 COPENHAGEN O,DENMARK
关键词
D O I
10.1074/jbc.270.28.16886
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The urokinase-type plasminogen activator receptor (uPAR) gene was disrupted in mice in order to explore the role of cell surface-associated plasminogen activation in development and hemostasis. Homozygous, uPAR(-/-) mice were born and survived to adulthood with no overt phenotypic abnormalities. There was no indication of loss of fetal animals based on the Mendelian pattern of transmission of the mutant uPAR gene. uPAR(-/-) mice carried no detectable uPAR in lung, spleen, and other tissues when measured both immunologically by Western blot analysis and functionally by ligand cross-linking analyses. In addition, activated peritoneal macrophages collected from uPAR(-/-) mice failed to promote plasminogen activation in vitro. The loss of the receptor also resulted in a redistribution of uPA in some tissues but had no impact on pro-uPA activation in the urogenital tract. Thus, in the absence of other challenging factors such as infection, injury, or other functional deficits, uPAR deficiency does not compromise fertility, development, or hemostasis. These mice provide a means to test the proposed function of uPA/uPAR in wound repair, atherogenesis, and tumor cell invasion in vivo.
引用
收藏
页码:16886 / 16894
页数:9
相关论文
共 50 条
  • [21] DIFFERENTIAL DETECTION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND 2 CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN AND MONKEY PLASMA
    MOLINARI, A
    GIORGETTI, C
    BONOMINI, L
    GERNA, M
    LANSEN, J
    GUREWICH, V
    FIBRINOLYSIS, 1992, 6 (01) : 17 - 26
  • [22] EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN COLON-DISEASE
    MISELJIC, S
    GALANDIUK, S
    MYERS, SD
    WITTLIFF, JL
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1995, 9 (06) : 413 - 417
  • [23] ON THE REVERSIBLE INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    LIJNEN, HR
    VANHOEF, B
    COLLEN, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (07) : 4041 - 4044
  • [24] PLASMINOGEN-ACTIVATOR IN HUMAN ECCRINE SWEAT IS A UROKINASE-TYPE
    TAKEMURA, T
    HIBINO, T
    SATO, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (04) : 611 - 611
  • [25] TYROSINE PHOSPHORYLATION OF HUMAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    BARLATI, S
    PARACINI, F
    BELLOTTI, D
    DEPETRO, G
    FEBS LETTERS, 1991, 281 (1-2) : 137 - 140
  • [26] MUTATIONS AFFECTING THE ACTIVITY OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    DAVIDOW, LS
    DUMAIS, DR
    SMYTH, AP
    GREER, J
    MOIR, DT
    PROTEIN ENGINEERING, 1991, 4 (08): : 923 - 928
  • [27] MIGRATING KERATINOCYTES EXPRESS UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    MORIOKA, S
    LAZARUS, GS
    BAIRD, JL
    JENSEN, PJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (04) : 418 - 423
  • [28] MODULATION OF LIPOXIDASE ACTIVITY BY UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    VANASWEGEN, CH
    DUTOIT, PJ
    DUPLESSIS, DJ
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1994, 51 (03): : 183 - 186
  • [29] AMILORIDE SELECTIVELY INHIBITS THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    VASSALLI, JD
    BELIN, D
    FEBS LETTERS, 1987, 214 (01) : 187 - 191
  • [30] NMR-STUDIES ON UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    NOWAK, UK
    SMITH, RAG
    DOBSON, CM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 159 - 159